Tabituximab barzuxetan
Tabituximab barzuxetan (OTSA101-DTPA-90Y) is a Yttrium-90-labeled radioimmunoconjugate targeting FZD-10. It exhibits antineoplastic activity and is a research tool for studying synovial sarcoma, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1612758-88-9
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog